JP2000504035A - イソ吉草酸cns抑制剤による痙縮、痙攣の治療 - Google Patents
イソ吉草酸cns抑制剤による痙縮、痙攣の治療Info
- Publication number
- JP2000504035A JP2000504035A JP10511976A JP51197698A JP2000504035A JP 2000504035 A JP2000504035 A JP 2000504035A JP 10511976 A JP10511976 A JP 10511976A JP 51197698 A JP51197698 A JP 51197698A JP 2000504035 A JP2000504035 A JP 2000504035A
- Authority
- JP
- Japan
- Prior art keywords
- isovaleric acid
- spasticity
- isovaleramide
- pharmaceutically acceptable
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. それによって、病態の少なくとも1つの症状が軽減される、CNS活性の軽 度の抑制によって軽減される病態の治療法において用いられる薬学的製剤の調製 における、イソ吉草酸、イソ吉草酸の薬学的に許容される塩、イソ吉草酸の薬学 的に許容されるエステル、およびイソ吉草酸の薬学的に許容されるアミドからな る群より選択される化合物の使用。 2.病態が情動性気分障害、痙攣、中枢神経障害性疼痛症候群、頭痛、および不 穏症候群からなる群より選択される、請求項1記載の使用。 3.病態が痙攣である、請求項2記載の使用。 4.病態が中枢によって媒介される筋緊張の低下によって軽減される、請求項1 記載の使用。 5.病態が痙縮である、請求項4記載の使用。 6.組成物がイソバレルアミドである請求項1記載の使用。 7.痙縮の症状の治療法において用いられる薬学的製剤の調製における、インビ ボで加水分解されてイソ吉草酸またはイソバレルアミドを生じる化合物を少なく とも1つ含む、カノコソウ、莢蓮皮、ガマズミ、またはホップの抽出物の使用。 8.CNS活性の軽度の減少によって軽減される病態を有する患者に、それによっ て該病態の少なくとも1つの症状が軽減される、薬学的に許容される担体とイソ 吉草酸、イソ吉草酸の薬学的に許容される塩、イソ吉草酸の薬学的に許容される エステル、およびイソ吉草酸の薬学的に許容されるアミドからなる群より選択さ れる組成物とを含む薬学的製剤の治療的有効量を投与する段階を含む治療法。 9.そのような治療を必要とする被験者において痙縮の症状を軽減する方法であ って、インビボで加水分解されてイソ吉草酸またはイソバレルアミドを生じる化 合物を少なくとも1つ含む、カノコソウ、莢蓮皮、ガマズミ、またはホップの抽 出物の治療的有効量を投与する段階を含む方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2505096P | 1996-08-30 | 1996-08-30 | |
US60/025,050 | 1996-08-30 | ||
PCT/US1997/015272 WO1998008498A1 (en) | 1996-08-30 | 1997-08-29 | Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000504035A true JP2000504035A (ja) | 2000-04-04 |
Family
ID=21823778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10511976A Ceased JP2000504035A (ja) | 1996-08-30 | 1997-08-29 | イソ吉草酸cns抑制剤による痙縮、痙攣の治療 |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0938304B1 (ja) |
JP (1) | JP2000504035A (ja) |
KR (1) | KR100594400B1 (ja) |
CN (2) | CN1531924A (ja) |
AT (1) | ATE284683T1 (ja) |
AU (1) | AU728765B2 (ja) |
BR (1) | BR9713188A (ja) |
CA (1) | CA2264577A1 (ja) |
DE (1) | DE69731968T2 (ja) |
DK (1) | DK0938304T3 (ja) |
ES (1) | ES2235251T3 (ja) |
HK (1) | HK1023725A1 (ja) |
IL (1) | IL128724A (ja) |
PT (1) | PT938304E (ja) |
RU (1) | RU2232016C2 (ja) |
WO (1) | WO1998008498A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004505999A (ja) * | 2000-08-17 | 2004-02-26 | テバ ファーマシューティカル インダストリーズ リミティド | 疼痛および/または頭痛疾患の治療または予防のための、バルプロ酸アミドおよび2−バルプロエン酸アミドの誘導体の使用 |
KR20180054381A (ko) * | 2016-11-15 | 2018-05-24 | 경희대학교 산학협력단 | 쥐오줌풀 추출물을 유효성분으로 포함하는 측두엽 뇌전증 예방 또는 치료용 약학적 조성물 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6589994B1 (en) * | 1996-08-30 | 2003-07-08 | Nps Pharmaceuticals, Inc. | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound |
AU2003204485B2 (en) * | 1998-03-04 | 2006-06-08 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
CA2321737A1 (en) * | 1998-03-04 | 1999-09-10 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
EP1576962A1 (en) * | 1998-03-04 | 2005-09-21 | Nps Pharmaceuticals, Inc. | Composition comprising isovaleramide and ibuprofen |
US6383527B1 (en) * | 1999-03-04 | 2002-05-07 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID |
US6346283B1 (en) | 1999-03-26 | 2002-02-12 | Ancile Pharmaceuticals | Use of valeriana for the treatment of restless leg syndrome and related disorders |
CA2387819A1 (en) * | 1999-10-19 | 2001-04-26 | Nps Pharmaceuticals, Inc. | Sustained-release formulations for treating cns-mediated disorders |
US7235258B1 (en) | 1999-10-19 | 2007-06-26 | Nps Pharmaceuticals, Inc. | Sustained-release formulations for treating CNS-mediated disorders |
AU2002243920A1 (en) * | 2001-02-08 | 2002-08-19 | Nps Pharmaceuticals, Inc. | Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
WO2003063605A1 (en) * | 2002-02-01 | 2003-08-07 | Eugene Science Inc. | Chewing gum composition containing plant sterol for decrease of flood cholesterol levels and prevention of periodontal disease |
US20060025477A1 (en) * | 2004-07-22 | 2006-02-02 | Artman Linda D | Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
DE102006062264A1 (de) * | 2006-12-22 | 2008-06-26 | Joh. Barth & Sohn Gmbh & Co. Kg | Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen |
RU2460534C1 (ru) * | 2011-04-15 | 2012-09-10 | Учреждение Российская академия наук Сибирское отделение (СО РАН) Институт общей и экспериментальной биологии (ИОЭБ СО РАН) | Способ получения средства, обладающего анксиолитической активностью |
CN103565959B (zh) * | 2013-11-06 | 2015-04-08 | 李传平 | 一种治疗精神分裂症的汤剂 |
CN103961341B (zh) * | 2014-05-30 | 2015-12-02 | 杨献华 | 一种治疗偏头痛的药物组合物及其应用 |
US10351519B2 (en) * | 2016-02-29 | 2019-07-16 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compounds, processes for preparing them and their uses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617555C3 (de) * | 1966-04-19 | 1974-09-19 | Kali-Chemie Ag, 3000 Hannover | Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten |
DE2230626B2 (de) * | 1972-06-22 | 1978-07-20 | Roland Dr. 7967 Bad Waldsee Schaette | Baldrianpräparat |
US5506268A (en) * | 1993-06-11 | 1996-04-09 | Nps Pharmaceuticals, Inc. | Use of isovaleramide as a mild anxiolytic and sedative agent |
-
1997
- 1997-08-29 IL IL12872497A patent/IL128724A/xx not_active IP Right Cessation
- 1997-08-29 DK DK97941381T patent/DK0938304T3/da active
- 1997-08-29 PT PT97941381T patent/PT938304E/pt unknown
- 1997-08-29 RU RU99106406/14A patent/RU2232016C2/ru not_active IP Right Cessation
- 1997-08-29 KR KR1019997001716A patent/KR100594400B1/ko not_active IP Right Cessation
- 1997-08-29 ES ES97941381T patent/ES2235251T3/es not_active Expired - Lifetime
- 1997-08-29 EP EP97941381A patent/EP0938304B1/en not_active Expired - Lifetime
- 1997-08-29 DE DE69731968T patent/DE69731968T2/de not_active Expired - Fee Related
- 1997-08-29 AT AT97941381T patent/ATE284683T1/de not_active IP Right Cessation
- 1997-08-29 AU AU43302/97A patent/AU728765B2/en not_active Ceased
- 1997-08-29 WO PCT/US1997/015272 patent/WO1998008498A1/en not_active Application Discontinuation
- 1997-08-29 JP JP10511976A patent/JP2000504035A/ja not_active Ceased
- 1997-08-29 CN CNA2004100342927A patent/CN1531924A/zh active Pending
- 1997-08-29 BR BR9713188-1A patent/BR9713188A/pt not_active Application Discontinuation
- 1997-08-29 CN CNB971992576A patent/CN1152677C/zh not_active Expired - Fee Related
- 1997-08-29 CA CA002264577A patent/CA2264577A1/en not_active Abandoned
-
2000
- 2000-05-16 HK HK00102920A patent/HK1023725A1/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004505999A (ja) * | 2000-08-17 | 2004-02-26 | テバ ファーマシューティカル インダストリーズ リミティド | 疼痛および/または頭痛疾患の治療または予防のための、バルプロ酸アミドおよび2−バルプロエン酸アミドの誘導体の使用 |
KR20180054381A (ko) * | 2016-11-15 | 2018-05-24 | 경희대학교 산학협력단 | 쥐오줌풀 추출물을 유효성분으로 포함하는 측두엽 뇌전증 예방 또는 치료용 약학적 조성물 |
Also Published As
Publication number | Publication date |
---|---|
DE69731968T2 (de) | 2005-12-22 |
DK0938304T3 (da) | 2005-03-14 |
IL128724A0 (en) | 2000-01-31 |
AU4330297A (en) | 1998-03-19 |
DE69731968D1 (de) | 2005-01-20 |
ATE284683T1 (de) | 2005-01-15 |
EP0938304B1 (en) | 2004-12-15 |
PT938304E (pt) | 2005-04-29 |
KR100594400B1 (ko) | 2006-07-03 |
IL128724A (en) | 2003-05-29 |
RU2232016C2 (ru) | 2004-07-10 |
BR9713188A (pt) | 1999-11-03 |
CN1531924A (zh) | 2004-09-29 |
CA2264577A1 (en) | 1998-03-05 |
HK1023725A1 (en) | 2000-09-22 |
AU728765B2 (en) | 2001-01-18 |
KR20000038194A (ko) | 2000-07-05 |
ES2235251T3 (es) | 2005-07-01 |
CN1235541A (zh) | 1999-11-17 |
EP0938304A1 (en) | 1999-09-01 |
WO1998008498A1 (en) | 1998-03-05 |
CN1152677C (zh) | 2004-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU779418B2 (en) | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound | |
JP2002538106A5 (ja) | ||
US6383527B1 (en) | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID | |
JP2000504035A (ja) | イソ吉草酸cns抑制剤による痙縮、痙攣の治療 | |
ES2409932T3 (es) | Composiciones farmacéuticas que comprenden trigonelina y 4-hidroxiisoleucina y su proceso de preparación | |
WO1998008498A9 (en) | Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants | |
EP1059930B1 (en) | Compositions comprising isovaleramide and ibuprofen | |
LU81294A1 (fr) | Procede pour causer de l'anorecie par administration buccale de naltrexone ou d'un sel de celle-ci | |
ES2681996A2 (es) | Composiciones para reducir el apetito y el ansia,potenciar la saciedad, mejorar el estado de animo y reducir el estres. | |
JPH10114649A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
JP6864964B2 (ja) | 経口睡眠改善剤 | |
EP1516619A2 (en) | Treatment of spasticity, convulsions by isovaleric acid derivatives CNS depressants | |
JPH10114650A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
MXPA99001956A (en) | Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants | |
RU2223108C1 (ru) | Средство, обладающее седативным, спазмолитическим, противовоспалительным, желчегонным, общеукрепляющим и отхаркивающим действием | |
AU2003204485B2 (en) | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid | |
JPH10114652A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
Givens et al. | Valerian | |
Laekeman | Assessment report on Cinnamomum verum JS Presl, cortex and corticisaetheroleum | |
EP1576962A1 (en) | Composition comprising isovaleramide and ibuprofen | |
Isetts | Valerian | |
BRPI0904010B1 (pt) | Uso de composição farmacêutica e uso do extrato oleoso de uma espécie vegetal do gênero alpinia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040721 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080129 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080701 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080812 |